RxDoctor Payments Data

Robert Okada

Cardiovascular Disease · Tulsa, OKNPI 1003816877

Payments from drug & device makers

$3,045in general payments, 2019–2025

Across 192 payments — averaging $15.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$439
  • Johnson & Johnson$433
  • Novartis$236
  • Boston Scientific$207
  • Abbott$202
  • Boehringer Ingelheim$200
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$3,00999%
  • Education$361%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,045 in reported general payments places this provider in the 45th percentile of 164 cardiovascular disease providers in Oklahoma.

See all cardiovascular disease providers in Oklahoma

Other cardiovascular disease in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →